19-38915624-G-GCCAGGCAGC
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The ENST00000221431.11(SARS2):c.1538_1539insGCTGCCTGG(p.Leu511_Gly513dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,612,656 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G513G) has been classified as Likely benign.
Frequency
Consequence
ENST00000221431.11 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SARS2 | NM_017827.4 | c.1538_1539insGCTGCCTGG | p.Leu511_Gly513dup | inframe_insertion | 16/16 | ENST00000221431.11 | NP_060297.1 | |
SARS2 | NM_001145901.2 | c.1544_1545insGCTGCCTGG | p.Leu513_Gly515dup | inframe_insertion | 17/17 | NP_001139373.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARS2 | ENST00000221431.11 | c.1538_1539insGCTGCCTGG | p.Leu511_Gly513dup | inframe_insertion | 16/16 | 1 | NM_017827.4 | ENSP00000221431 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00153 AC: 233AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00248 AC: 621AN: 250394Hom.: 7 AF XY: 0.00279 AC XY: 378AN XY: 135342
GnomAD4 exome AF: 0.00232 AC: 3394AN: 1460360Hom.: 17 Cov.: 33 AF XY: 0.00240 AC XY: 1745AN XY: 726408
GnomAD4 genome AF: 0.00154 AC: 235AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 02, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 22, 2021 | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
SARS2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 20, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at